Related references
Note: Only part of the references are listed.Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma
Antonio Pea et al.
HEPATOLOGY (2021)
Pancreatic Cancer: From Genome Discovery to PRECISION-Panc
S. B. Dreyer et al.
CLINICAL ONCOLOGY (2020)
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+Cells
Pietro Carotenuto et al.
HEPATOLOGY (2020)
Intracellular Chloride Channels: Novel Biomarkers in Diseases
Shubha Gururaja Rao et al.
FRONTIERS IN PHYSIOLOGY (2020)
ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.
Paula Ghaneh et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor
Yingying Zhou et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Noncoding RNA in Cholangiocarcinoma
Massimiliano Salati et al.
SEMINARS IN LIVER DISEASE (2019)
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer
Sofia Palacio et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
Andrea Lampis et al.
GASTROENTEROLOGY (2018)
MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours
Michele Ghidini et al.
TARGETED ONCOLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Kyaw L. Aung et al.
CLINICAL CANCER RESEARCH (2018)
Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
Victor Hugo Fonseca de Jesus et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX
Amikar Sehdev et al.
CLINICAL CANCER RESEARCH (2018)
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
Pietro Carotenuto et al.
GUT (2017)
Mitochondrial ROS control of cancer
Maria del Pilar Sosa Idelchik et al.
SEMINARS IN CANCER BIOLOGY (2017)
MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer
Haifei He et al.
TUMOR BIOLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
irCLIP platform for efficient characterization of protein-RNA interactions
Brian J. Zarnegar et al.
NATURE METHODS (2016)
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial
Khurum Khan et al.
ONCOTARGET (2016)
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models
M. W. van Gisbergen et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
Absolute quantification of cell-free microRNAs in cancer patients
Manuela Ferracin et al.
ONCOTARGET (2015)
MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
Adam E. Frampton et al.
GASTROENTEROLOGY (2014)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Locally Advanced Pancreatic Cancer Association Between Prolonged Preoperative Treatment and Lymph-Node Negativity and Overall Survival
Brian E. Kadera et al.
JAMA SURGERY (2014)
Serum miR-1290 as a Marker of Pancreatic Cancer-Response
Ang Li et al.
CLINICAL CANCER RESEARCH (2013)
Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
Sophie Gourgou-Bourgade et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance
Ming-Zhe Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
Brian A. Boone et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Peter J. Hosein et al.
BMC CANCER (2012)
CLIC4 is a tumor suppressor for cutaneous squamous cell cancer
K. Stephen Suh et al.
CARCINOGENESIS (2012)
MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Nigel B. Jamieson et al.
CLINICAL CANCER RESEARCH (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
C. Braconi et al.
ONCOGENE (2011)
Guidelines for the welfare and use of animals in cancer research
P. Workman et al.
BRITISH JOURNAL OF CANCER (2010)
Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes
Chiara Braconi et al.
CLINICAL CANCER RESEARCH (2010)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
Rafael Rosell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MicroRNA expression profiling: A molecular tool for defining, the phenotype of hepatocellular tumors
Chiara Braconi et al.
HEPATOLOGY (2008)
Functional reconstitution of mammalian 'chloride intracellular channels' CLIC1, CLIC4 and CLIC5 reveals differential regulation by cytoskeletal actin
H. Singh et al.
FEBS JOURNAL (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)